Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 41 4
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
VH-Fc ab8 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/29/2021 2 0
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Palbociclib Potential treatment - theoretical effect Used to treat other disease Other treatment Apr/12/2021 3 0
Pentamidine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021 2 0
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021 12 0
Quercetin Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021 12 0
Luteolin Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021 4 0
Excel (.xslx) CSV (.csv)